Filing Details
- Accession Number:
- 0001225208-17-017130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-09 14:16:18
- Reporting Period:
- 2017-11-07
- Accepted Time:
- 2017-11-09 14:16:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Vice Chairman, Pres. And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-07 | 33,435 | $136.37 | 76,331 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-07 | 33,435 | $333.31 | 42,896 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2017-11-07 | 33,435 | $0.00 | 33,435 | $136.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,145 | 2023-12-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,018 | Indirect | 401(k) Plan |
Footnotes
- Represents the weighted average sales price for price increments ranging from $332.92 to $333.68. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Includes 51.259 shares acquired under the Company's 401(k) Plan from February 4, 2017 to August 4, 2017.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant 33,435 options fully vested and the remaining options vest on December 11, 2017.